ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

YOUR HEALTH: Stem cell therapy that helps restore lost sight – WQAD.com

Continue reading

2018-05-05 Michael Zand NEWS

Stem cell therapy for the heart: hype or hope? – The Business Times


WQAD.com

YOUR HEALTH: Stem cell therapy that helps restore lost sight
WQAD.com
“In 2010, I did the first ocular retinal stem cell surgery in Düsseldorf, Germany.” Since then, Dr. Weiss says his procedure is now FDA-compliant in the United States. Weiss uses stem cells from the patient’s own bone marrow. “These are your stem cells …

Continue reading

2018-05-04 Michael Zand NEWS

New Alzheimer’s and Parkinson’s Immunotherapy Data at AAN – Alzforum


The Business Times

Stem cell therapy for the heart: hype or hope?
The Business Times
STEM cell treatment continues to be bandied around as the “magic ” bullet for many health conditions. It is time to take stock of the state of technology concerning the use of stem cells in heart disease. The normal heart cell. The first thing we need …
Fasting may boost stem cell regeneration: study – The HinduThe Hindu
Fasting boosts stem cells‘ regenerative capacityScienceBlog.com (blog)
Dr. Luga Podesta on stem cells in orthopedics, ‘a new frontier in medicine’Becker’s Orthopedic & Spine
The Tribune –Technology Networks –The Indian Express
all 34 news articles »
Continue reading

2018-05-04 Michael Zand NEWS

New Alzheimer’s and Parkinson’s Immunotherapy Data at AAN – Alzforum

New Alzheimer’s and Parkinson’s Immunotherapy Data at AAN
Alzforum
For neurodegeneration researchers, highlights at the 2018 conference of the American Academy of Neurology, held April 21 to 27 in Los Angeles, California, were centiloid analysis of PET scans, the latest cognition update from people treated with the …

Continue reading

2018-05-04 Michael Zand NEWS

Before he died, this biohacker was planning a CRISPR trial in Mexico – MIT Technology Review

MIT Technology ReviewBefore he died, this biohacker was planning a CRISPR trial in MexicoMIT Technology ReviewThe controversial biohacker Aaron Traywick, who was found dead in a sensory deprivation tank in Washington, DC, this week, appear to have been… Continue reading

2018-05-04 Michael Zand NEWS

Hackensack Meridian joins NJII’s gene therapy center – NJBIZ

New Alzheimer’s and Parkinson’s Immunotherapy Data at AAN
Alzforum
For neurodegeneration researchers, highlights at the 2018 conference of the American Academy of Neurology, held April 21 to 27 in Los Angeles, California, were centiloid analysis of PET scans, the latest cognition update from people treated with the …

Continue reading

2018-05-04 Michael Zand NEWS

Hackensack Meridian joins NJII’s gene therapy center – NJBIZ


NJBIZ

Hackensack Meridian joins NJII’s gene therapy center
NJBIZ
Hackensack Meridian Health has become part the New Jersey Innovation Institute’s Cell and Gene Therapy Development Center. HMH will have access to NJII’s process development and clinical manufacturing capabilities, as well as the center’s training and …

Continue reading

2018-05-04 Michael Zand NEWS

HCT Following CAR T-Cell Therapy May Improve Patient Outcomes in ALL – Targeted Oncology

Targeted OncologyHCT Following CAR T-Cell Therapy May Improve Patient Outcomes in ALLTargeted OncologyResults of an interim analysis from a small phase I trial presented at the 2018 American Society of Pediatric Hematology/Oncology Conference showed th… Continue reading

2018-05-04 Michael Zand NEWS
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

NJBIZ

Hackensack Meridian joins NJII’s gene therapy center
NJBIZ
Hackensack Meridian Health has become part the New Jersey Innovation Institute’s Cell and Gene Therapy Development Center. HMH will have access to NJII’s process development and clinical manufacturing capabilities, as well as the center’s training and …